Kyongbo Pharmaceutical Co Ltd
KRX:214390
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
KR |
|
Beijing North Star Co Ltd
SSE:601588
|
CN |
|
DKSH Holding AG
SIX:DKSH
|
CH |
|
Pinnacle Investment Management Group Ltd
ASX:PNI
|
AU |
|
W
|
Wistron NeWeb Corp
TWSE:6285
|
TW |
|
Concordia Maritime AB
STO:CCOR B
|
SE |
|
Sensys Gatso Group AB
STO:SENS
|
SE |
|
K
|
Kredyt Inkaso SA
WSE:KRI
|
PL |
|
Brass Corp
TSE:2424
|
JP |
|
Keikyu Corp
TSE:9006
|
JP |
|
N
|
Northbaze Group AB
STO:NBZ
|
SE |
|
K
|
Kina Securities Ltd
ASX:KSL
|
PG |
|
K
|
Kato Works Co Ltd
TSE:6390
|
JP |
|
S
|
SDI Group PLC
LSE:SDI
|
UK |
|
H
|
Hellenic Telecommunications Organization SA
ATHEX:HTO
|
GR |
|
HAXC Holdings Beijing Co Ltd
SZSE:300928
|
CN |
|
Hugo Boss AG
XETRA:BOSS
|
DE |
|
J
|
Jiangsu Hongdou Industrial Co Ltd
SSE:600400
|
CN |
|
WDB Holdings Co Ltd
TSE:2475
|
JP |
|
Nihon Shokuhin Kako Co Ltd
TSE:2892
|
JP |
|
W
|
Wearable Devices Ltd
NASDAQ:WLDS
|
IL |
|
ScanTech AI Systems Inc
NASDAQ:STAI
|
US |
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
AU |
Bankruptcy Probability
Kyongbo Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kyongbo Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
190.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kyongbo Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kyongbo Pharmaceutical Co Ltd has total debt of 126.5B KRW. This includes both short-term (101.3B KRW) and long-term (25.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
